首页> 外文OA文献 >Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck

【2h】

Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck

机译：甲氨蝶呤，长调温剂，多柔比星和顺铂患者的鳞状细胞癌的头部和颈部的鳞状细胞癌

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Scott H. Okuno; James A. Mailliard; Vera J. Suman; John H. Edmonson; Edward T. Creagan; Suresh Nair; Ralph Levitt; John W. Kugler;
展开▼
作者单位

展开▼
年度 2002
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck [J] . Mamoru Tsukuda, Junichi Ishitoya, Hideki Matsuda, Cancer Chemotherapy and Pharmacology . 2010,第4期

机译：多西他赛，顺铂和5-氟尿嘧啶同时放化疗联合CCRT联合顺铂，5-氟尿嘧啶，甲氨蝶呤和亚叶酸的随机对照II期比较研究在局部晚期头颈部鳞状细胞癌患者中的应用
2. Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck. [J] . Tsukuda M, Ishitoya J, Matsuda H, Cancer chemotherapy and pharmacology. . 2010,第4期

机译：随机对照期同期对多西紫杉醇，顺铂和5氟尿嘧啶与顺铂，5-氟尿嘧啶，甲氨蝶呤和白草素患者的头部和颈部临床和颈部癌症的随机化学疗法对比研究。
3. Second-line chemotherapy with bleomycin, methotrexate, and vinorelbine (BMV) for patients with squamous cell carcinoma of the head, neck and esophagus (SCC-HN&E) pretreated with a cisplatin-containing regimen: a phase II study. [J] . Moroni M, Giannetta L, Gelosa G, Journal of chemotherapy . 2003,第4期

机译：博莱霉素，甲氨蝶呤和长春瑞滨（BMV）的二线化疗对头，颈和食道鳞状细胞癌（SCC-HN＆E）的患者进行了含顺铂方案的预处理：II期研究。
4. CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma [C] . Zhien Feng, Lizhen Wang, Bingshun Wang, Academic Committee Conference of Shanghai key lab of stomatology . 2011

机译：CCND1作为局部晚期头颈部鳞状细胞癌患者新辅助化疗的预测生物标志物
5. EGFRvIII Expression and Signaling in head and neck squamous cell carcinoma. [D] . Wheeler, Sarah E. 2012

机译：EGFRvIII在头颈部鳞状细胞癌中的表达和信号传导。
6. Design of a randomized controlled phase III study of dose dense methotrexate vinblastine doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial [O] . Christian Pfister, Valentin Harter, Yves Allory, 2020

机译：剂量密集的甲氨蝶呤长春碱阿霉素和顺铂（dd-MVAC）或吉西他滨和顺铂（GC）作为围手术期化疗的局部晚期膀胱癌患者的随机对照III期研究设计。法国GETUG / AFU V05 VESPER试用版
7. Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial [O] . Christian Pfister, Valentin Harter, Yves Allory, 2020

机译：随机对照甲尾甲醇三甲产蛋白，长霉素，多柔比星和顺铂（DD-MVAC）或吉西他滨和顺铂（GC）的患者为膀胱局部晚期过渡细胞癌患者的患者的随机致密甲氨蝶呤（DD-MVAC）或吉西他滨和顺铂（GC）的设计。法国Getug / AFU V05 Vesper试用

Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck

著录项

引文网络

相似文献

相关主题

期刊订阅